This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Gold Regains Shine on US-China Trade War Truce
by Zacks Equity Research
Gold prices jumped on Dec 3 as the U.S. dollar retreated on news of a "ceasefire" in the US-China trade war.
Trinseo (TSE) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Weakness across automotive and tire markets, slowdown in China and higher raw materials costs are likely to impact Trinseo's (TSE) results in Q3.
4 Toxic Stocks to Abandon or Sell Short for Solid Gains
by Zacks Equity Research
Overblown toxic stocks are usually vulnerable to external shocks and loaded with a huge amount of debt.
Can Albemarle (ALB) Beat Earnings in Q3 on Lithium Strength?
by Anindya Barman
Albemarle (ALB) is likely to gain from favorable pricing and volume trends in its Lithium segment in Q3.
Air Products (APD) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Higher expected revenues across most segments along with productivity actions are likely to support Air Products' (APD) Q4 results.
FMC Corp (FMC) to Post Q3: Will the Earnings Streak Continue?
by Anindya Barman
Strong segment performance is expected to support FMC Corp.'s (FMC) Q3 results.
Mosaic (MOS) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Higher realized prices to support Mosaic's (MOS) third-quarter 2018 results.
Zacks.com featured highlights include: AMC, InterXion, Osisko and Agnico
by Zacks Equity Research
Zacks.com featured highlights include: AMC, InterXion, Osisko and Agnico
4 Toxic Stocks to Discard or Sell Short for Solid Gains
by Zacks Equity Research
Overpriced toxic stocks are usually vulnerable to outside shocks and burdened with a huge amount of debt.
Zacks.com featured highlights include: First Majestic, Agnico Eagle, AMC and Osisko
by Zacks Equity Research
Zacks.com featured highlights include: First Majestic, Agnico Eagle, AMC and Osisko
4 Toxic Stocks to Abandon or Sell Short for Solid Gains
by Zacks Equity Research
Overhyped toxic stocks are generally vulnerable to external shocks and burdened with a huge amount of debt.
Zacks.com featured highlights include: Cardiovascular, AMC, Osisko and Agnico Eagle
by Zacks Equity Research
Zacks.com featured highlights include: Cardiovascular, AMC, Osisko and Agnico Eagle
4 Toxic Stocks to Get Rid Off or Sell Short for Solid Gains
by Zacks Equity Research
Pricey toxic stocks are usually vulnerable to external shocks and loaded with a huge amount of debt.
4 Toxic Stocks to Abandon or Sell Short for Solid Gains
by Zacks Equity Research
Overpriced toxic stocks are generally susceptible to external shocks and loaded with a high level of debt.
Can Osisko Gold Royalties (OR) Run Higher on Strong Earnings Estimate Revisions?
by Zacks Equity Research
Osisko Gold Royalties (OR) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
Mining Stocks to Watch for Q1 Earnings on May 3: AUY, HBM, OR
by Zacks Equity Research
Let's have a sneak peek into three mining companies that are slated to report first-quarter 2017 results on May 3.